10-Q Filing

ST JUDE MEDICAL INC CIK: 203077 Q1 2010

Filing Information

Form Type	10-Q
Accession Number	`0000897101-10-000919`
Period End Date	20100331
Filing Date	20100504
Fiscal Year	2010
Fiscal Period	Q1
XBRL Instance	stj-20100403.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 80 Income Statement 28 Cash Flow Statement 53

Balance Sheet 80 line items

Line Item	Tag	Value	Unit	Period
Accounts receivable, allowance for doubtful accounts	`AllowanceForDoubtfulAccountsReceivableCurrent`	$35.28M	USD	Point-in-time
Accounts receivable, allowance for doubtful accounts	`AllowanceForDoubtfulAccountsReceivableCurrent`	$34.95M	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$1.00	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$1.00	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$529.87M	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	25.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$392.93M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$136.44M	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	25.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$325.25M	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	-	shares	Point-in-time
Accounts receivable, less allowance for doubtful accounts of $35,276 at April 3, 2010 and $34,947 at January 2, 2010	`AccountsReceivableNetCurrent`	$1.21B	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	-	shares	Point-in-time
Accounts receivable, less allowance for doubtful accounts of $35,276 at April 3, 2010 and $34,947 at January 2, 2010	`AccountsReceivableNetCurrent`	$1.17B	USD	Point-in-time
Inventories	`InventoryNet`	$683.79M	USD	Point-in-time
Inventories	`InventoryNet`	$659.96M	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.10	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.10	USD	Point-in-time
Deferred income taxes, net	`DeferredTaxAssetsNetCurrent`	$164.74M	USD	Point-in-time
Deferred income taxes, net	`DeferredTaxAssetsNetCurrent`	$164.75M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	500.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	500.00M	shares	Point-in-time
Other	`OtherAssetsCurrent`	$174.63M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	326.19M	shares	Point-in-time
Other	`OtherAssetsCurrent`	$172.00M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	324.54M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$2.76B	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	326.19M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$2.56B	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	324.54M	shares	Point-in-time
Property, plant and equipment, at cost	`PropertyPlantAndEquipmentGross`	$1.95B	USD	Point-in-time
Property, plant and equipment, at cost	`PropertyPlantAndEquipmentGross`	$1.99B	USD	Point-in-time
Less: accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$807.12M	USD	Point-in-time
Less: accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$796.33M	USD	Point-in-time
Net property, plant and equipment	`PropertyPlantAndEquipmentNet`	$1.18B	USD	Point-in-time
Net property, plant and equipment	`PropertyPlantAndEquipmentNet`	$1.15B	USD	Point-in-time
Goodwill	`Goodwill`	$2.01B	USD	Point-in-time
Goodwill	`Goodwill`	$2.00B	USD	Point-in-time
Other intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$441.60M	USD	Point-in-time
Other intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$456.14M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$263.05M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$250.53M	USD	Point-in-time
TOTAL ASSETS	`Assets`	$6.43B	USD	Point-in-time
TOTAL ASSETS	`Assets`	$6.65B	USD	Point-in-time
Current portion of long-term debt	`DebtCurrent`	$224.93M	USD	Point-in-time
Current portion of long-term debt	`DebtCurrent`	$334.79M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$132.54M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$91.41M	USD	Point-in-time
Income taxes payable	`AccruedIncomeTaxesCurrent`	$64.66M	USD	Point-in-time
Income taxes payable	`AccruedIncomeTaxesCurrent`	$13.50M	USD	Point-in-time
Employee compensation and related benefits	`EmployeeRelatedLiabilitiesCurrent`	$269.29M	USD	Point-in-time
Employee compensation and related benefits	`EmployeeRelatedLiabilitiesCurrent`	$240.34M	USD	Point-in-time
Other	`OtherLiabilitiesCurrent`	$270.32M	USD	Point-in-time
Other	`OtherLiabilitiesCurrent`	$317.19M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$891.66M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.07B	USD	Point-in-time
Long-term debt	`LongTermDebtNoncurrent`	$1.71B	USD	Point-in-time
Long-term debt	`LongTermDebtNoncurrent`	$1.59B	USD	Point-in-time
Deferred income taxes, net	`DeferredTaxLiabilitiesNoncurrent`	$136.49M	USD	Point-in-time
Deferred income taxes, net	`DeferredTaxLiabilitiesNoncurrent`	$132.39M	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$314.94M	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$333.89M	USD	Point-in-time
Total liabilities	`Liabilities`	$3.07B	USD	Point-in-time
Total liabilities	`Liabilities`	$3.10B	USD	Point-in-time
Preferred stock ($1.00 par value; 25,000,000 shares authorized; none outstanding)	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock ($1.00 par value; 25,000,000 shares authorized; none outstanding)	`PreferredStockValue`	-	USD	Point-in-time
Common stock ($0.10 par value; 500,000,000 shares authorized; 326,186,973 and 324,537,581 shares issued and outstanding at April 3, 2010 and January 2, 2010, respectively)	`CommonStockValue`	$32.62M	USD	Point-in-time
Common stock ($0.10 par value; 500,000,000 shares authorized; 326,186,973 and 324,537,581 shares issued and outstanding at April 3, 2010 and January 2, 2010, respectively)	`CommonStockValue`	$32.45M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$70.81M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$5.86M	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$3.43B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$3.19B	USD	Point-in-time
Cumulative translation adjustment	`AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax`	$29.66M	USD	Point-in-time
Cumulative translation adjustment	`AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax`	$82.03M	USD	Point-in-time
Unrealized gain on available-for-sale securities	`AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$12.00M	USD	Point-in-time
Unrealized gain on available-for-sale securities	`AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$11.95M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$3.32B	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$3.57B	USD	Point-in-time
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY	`LiabilitiesAndStockholdersEquity`	$6.43B	USD	Point-in-time
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY	`LiabilitiesAndStockholdersEquity`	$6.65B	USD	Point-in-time

Income Statement 28 line items

Line Item	Tag	Value	Unit	Period
Net sales	`SalesRevenueNet`	$1.13B	USD	1 Quarter
Net sales	`SalesRevenueNet`	$1.26B	USD	1 Quarter
Cost of sales	`CostOfGoodsSold`	$321.17M	USD	1 Quarter
Cost of sales	`CostOfGoodsSold`	$294.50M	USD	1 Quarter
Gross profit	`GrossProfit`	$839.30M	USD	1 Quarter
Gross profit	`GrossProfit`	$940.53M	USD	1 Quarter
Selling, general and administrative expense	`SellingGeneralAndAdministrativeExpense`	$417.68M	USD	1 Quarter
Selling, general and administrative expense	`SellingGeneralAndAdministrativeExpense`	$443.29M	USD	1 Quarter
Research and development expense	`ResearchAndDevelopmentExpense`	$151.23M	USD	1 Quarter
Research and development expense	`ResearchAndDevelopmentExpense`	$139.35M	USD	1 Quarter
Operating profit	`OperatingIncomeLoss`	$282.27M	USD	1 Quarter
Operating profit	`OperatingIncomeLoss`	$346.01M	USD	1 Quarter
Other income (expense), net	`OtherNonoperatingIncomeExpense`	$-7.31M	USD	1 Quarter
Other income (expense), net	`OtherNonoperatingIncomeExpense`	$-20.32M	USD	1 Quarter
Earnings before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$274.96M	USD	1 Quarter
Earnings before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$325.69M	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$87.12M	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$73.69M	USD	1 Quarter
Net earnings	`NetIncomeLoss`	$201.27M	USD	1 Quarter
Net earnings	`NetIncomeLoss`	$238.57M	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$0.73	USD	1 Quarter
Basic	`EarningsPerShareBasic`	$0.58	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$0.73	USD	1 Quarter
Diluted	`EarningsPerShareDiluted`	$0.58	USD	1 Quarter
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	325.31M	shares	1 Quarter
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	345.85M	shares	1 Quarter
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	328.06M	shares	1 Quarter
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	349.81M	shares	1 Quarter

Cash Flow Statement 53 line items

Line Item	Tag	Value	Unit	Period
Net earnings	`NetIncomeLoss`	$201.27M	USD	1 Quarter
Net earnings	`NetIncomeLoss`	$238.57M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$51.10M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$58.82M	USD	1 Quarter
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	$217.00K	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$17.79M	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$13.82M	USD	1 Quarter
Excess tax benefits from stock-based compensation	`ExcessTaxBenefitFromShareBasedCompensationOperatingActivities`	$5.15M	USD	1 Quarter
Excess tax benefits from stock-based compensation	`ExcessTaxBenefitFromShareBasedCompensationOperatingActivities`	$4.62M	USD	1 Quarter
Deferred income taxes	`DeferredIncomeTaxesAndTaxCredits`	$-8.74M	USD	1 Quarter
Deferred income taxes	`DeferredIncomeTaxesAndTaxCredits`	$-4.08M	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$39.68M	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$69.71M	USD	1 Quarter
Inventories	`IncreaseDecreaseInInventories`	$18.43M	USD	1 Quarter
Inventories	`IncreaseDecreaseInInventories`	$32.64M	USD	1 Quarter
Other current assets	`IncreaseDecreaseInOtherOperatingAssets`	$12.76M	USD	1 Quarter
Other current assets	`IncreaseDecreaseInOtherOperatingAssets`	$5.06M	USD	1 Quarter
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-72.78M	USD	1 Quarter
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-104.20M	USD	1 Quarter
Income taxes payable	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$38.99M	USD	1 Quarter
Income taxes payable	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$57.81M	USD	1 Quarter
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$133.71M	USD	1 Quarter
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$192.47M	USD	1 Quarter
Purchases of property, plant and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$80.84M	USD	1 Quarter
Purchases of property, plant and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$75.58M	USD	1 Quarter
Business acquisition payments, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$6.01M	USD	1 Quarter
Business acquisition payments, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$34.30M	USD	1 Quarter
Other, net	`PaymentsForProceedsFromOtherInvestingActivities`	$2.20M	USD	1 Quarter
Other, net	`PaymentsForProceedsFromOtherInvestingActivities`	$2.86M	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-112.08M	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-89.71M	USD	1 Quarter
Proceeds from exercise of stock options and stock issued	`ProceedsFromStockOptionsExercised`	$16.01M	USD	1 Quarter
Proceeds from exercise of stock options and stock issued	`ProceedsFromStockOptionsExercised`	$41.11M	USD	1 Quarter
Excess tax benefits from stock-based compensation	`ExcessTaxBenefitFromShareBasedCompensationFinancingActivities`	$4.62M	USD	1 Quarter
Excess tax benefits from stock-based compensation	`ExcessTaxBenefitFromShareBasedCompensationFinancingActivities`	$5.15M	USD	1 Quarter
Borrowings under debt facilities	`ProceedsFromIssuanceOfLongTermDebt`	$447.05M	USD	1 Quarter
Borrowings under debt facilities	`ProceedsFromIssuanceOfLongTermDebt`	$222.00M	USD	1 Quarter
Payments under debt facilities	`RepaymentsOfLongTermDebt`	$432.00M	USD	1 Quarter
Payments under debt facilities	`RepaymentsOfLongTermDebt`	$91.40M	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$151.76M	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$60.79M	USD	1 Quarter
Effect of currency exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashAndCashEquivalents`	$-4.23M	USD	1 Quarter
Effect of currency exchange rate changes on cash and cash equivalents	`EffectOfExchangeRateOnCashAndCashEquivalents`	$-6.94M	USD	1 Quarter
Net increase in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$188.81M	USD	1 Quarter
Net increase in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$136.95M	USD	1 Quarter
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$136.44M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$325.25M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$529.87M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$392.93M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$325.25M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$529.87M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$136.44M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$392.93M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.